Concord Medical Services Holdings Limited
(CCM)
Add Watchlist
0.50 USD +0.08
Closed: 17 May, 3:55 pm
Symbol CCM
Market Cap 18.9M
Price 0.50
Open 0.60
52-wk High 1.60
50 Day Avg 0.56
Earnings Announcement 2024-09-23
Website https://www.concordmedical.com
Name Concord Medical Services Holdings Limited
Shares Outstanding 37,636,936
Change % -3.398%
Low 0.46
52-wk Low 0.38
200 Day Avg 0.95
Last Dividend 0.00
Exchange NYSE
Volume 18,488
Previous Close 0.52
High 0.61
EPS -0.94
PE -0.54
Avg Volume 14,732
CUSIP 206277105
Concord Medical Services Holdings Limited Outlook
Description Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2021, it operated a network of 16 cooperative centers based in 13 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
Currency USD
ISIN US2062771058
Industry Medical - Care Facilities
Changes -0.02
CUSIP 206277105
Range 0.38 - 1.60
Beta -0.34
CIK 0001472072

Concord Medical Services Holdings Limited News

19-Apr-2024 8:31 AM

Concord Medical Files 2023 Annual Report on Form 20-F

BEIJING , April 19, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 (the "Annual Report") with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed on Concord Medical's investor relations website at http://ir.ccm.cn and on the SEC's website at www.sec.gov.

28-Mar-2024 3:38 PM

Canagold Resources Ltd. Announces Closing of $4.1M Charity Flow Through Financing

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) (the "Company" or "Canagold"), is pleased to announce it has closed a charity flow-through financing with Sun Valley Investments AG (“Sun Valley”). The Company issued 15,700,000 common shares of the Company (the “FT Share”) that qualify as flow-through shares for the purposes of the Income Tax Act (Canada) at a price of $0.2625 per FT Share for total gross proceeds of $4,121,500 (the.

20-Feb-2024 7:00 AM

Concord Medical Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price

BEIJING , Feb. 20, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it has received a letter (the "Letter") from the New York Stock Exchange (the "NYSE") dated February 12, 2024, notifying the Company that it is below compliance standards due to the trading price of the Company's American depositary shares (the "ADSs") and that the applicable cure period for the Company to regain compliance expires on August 12, 2024. Pursuant to applicable NYSE continued listing standards, a company would be considered "below criteria" by the NYSE if the average closing price of a security as reported on the consolidated tape is less than $1.00 over a consecutive 30 trading-day period.

09-Jan-2024 7:00 AM

Concord Medical Announces Listing of Its Subsidiary on The Stock Exchange of Hong Kong Limited

BEIJING , Jan. 9, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced the listing of a minority stake of 39,420,200 H shares in Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), its subsidiary, at an initial public offer price of HK$14.28 per H share on the Main Board of The Stock Exchange of Hong Kong Limited (the "HKSE") under the stock code 2453.HK.

04-Jan-2024 7:30 AM

Canagold Appoints Chris Pharness as Senior Vice President Sustainability and Permitting

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) (“Canagold” or the “Company”) announces today that the Company has appointed Mr. Chris Pharness as Senior Vice President Sustainability and Permitting, effective immediately. Mr. Pharness has 30 years of experience as an Environmental Professional. He has a proven record of success in community engagement, relationship building and negotiation, and demonstrated achievement in project.

20-Nov-2023 4:00 PM

Concord Medical Schedules 2023 Annual Meeting of Shareholders

BEIJING , Nov. 20, 2023 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that it will hold its 2023 annual general meeting of shareholders (the "Meeting") on December 26, 2023, at 10:00 a.m. (Beijing Time).

22-Sep-2023 5:00 PM

Concord Medical Reports Financial Results for the First Half of 2023

BEIJING , Sept. 22, 2023 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the six months ended June 30, 2023 [1].

11-Aug-2022 9:25 AM

Cincom® Integrates with Duck Creek to Streamline Customer Communication Processes for Insurers

CINCINNATI, Aug. 11, 2022 /PRNewswire/ — Cincom Systems®, a global provider of Customer Communications Management (CCM) solutions, announced today it has integrated with Duck Creek’s insurance suite to help insurers accelerate the digital transformation of their customer communications processes across the entire customer lifecycle. The combined power of Duck Creek and Cincom Eloquence® enables insurers […]...

24-Jul-2022 10:10 PM

FUJIFILM Business Innovation Hong Kong and Quadient Celebrate 10-year Partnership

60% of customer communication management (CCM) solutions portfolio from FUJIFILM Business Innovation Hong Kong and Quadient are international insurance companies. HONG KONG, July 25, 2022 /PRNewswire/ — Quadient (Euronext Paris: QDT), a leader in helping businesses create meaningful customer connections through digital and physical channels, and FUJIFILM Business Innovation Hong Kong Limited (FUJIFILM BI Hong Kong), a […]...

10-Nov-2021 1:28 PM

Presto Completes $1B SPAC Merger to Go Public

Restaurant-technology startup Presto will have a valuation of about $1 billion when it goes public through special purpose acquisition company (SPAC) Ventoux CCM Acquisition Corp., the companies told The Wall Street Journal Wednesday (Nov. 10).  The $170 million Ventoux CCM SPAC, which is led by former hospitality execs and backed by investment bank Chardan Capital […]

18-Oct-2021 4:08 AM

Concord Medical Is Shortlisted for the "5G+Healthcare" Pilot Project

BEIJING, Oct. 18, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, today announced that two projects of it, Jiahe Cloud Imaging Remote Medical Information Diagnosis Platform ("Jiahe Cloud") and Jiahe Feiyun Intelligent Radiotherapy Cloud Service Platform ("Jiahe Feiyun"), were successfully shortlisted by the "5G+Healthcare" pilot project, which is launched by Ministry of Industry and Information Technology. Jiahe Cloud provides digitized solutions, with remote diagnosis as the core service, for medical institutions.